A bioartificial pancreas is the current therapy that researchers are investigating as an effective treatment option in both T1D and T2D; this would ideally be capable of supplying a sufficient amount of insulin and will be discussed throughout this review [26,29]. The gene discussed is INS; the disease is type 2 diabetes mellitus.